APAC eClinical Solutions Market Size (2021 to 2026)
The size of the Asia-Pacific eClinical Solutions Market is predicted to grow faster from 2021 to 2026.
The existence of a robust urban population, growing assumption of cloud-based technology for the enhancements of e-clinical solutions, and Y-O-Y growth in the clinical research activities among the existing economies of Asia Pacific are majorly driving the eClinical Solutions market during the forecast period. The expansion of pharmaceutical industries is a favorable factor in market growth. An increase in the number of trials contracted in countries such as China, India, Korea, and Japan due to the large population count is a significant factor in the Asia Pacific's eClinical solutions market.
The low acceptance rate in a few countries of this region is expected to show a little negative impact on the market's growth. High costs associated with the e-Clinical solutions market is predicted to hinder the market growth to a small extent.
This research report on the Asia Pacific eClinical Solutions market has been segmented & sub-segmented into the following categories:
By Product:
- Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
- Clinical Trial Management Systems (CTMS)
- Clinical Analytics Platform
- Randomization and Trial Supply Management (RTMS)
- Clinical Data Integration Platform
- Electronic Clinical Outcome Assessment (eCOA)
- Safety Solutions
- Electronic Trial Master Files (eTMF)
- Regulatory Information Management Solutions (RIMS)
- Others
By Delivery Mode:
- Web-hosted (On-demand)
- Licensed Enterprise (On-premise)
- Cloud-based
By Development Phase:
- Phase I
- Phase II
- Phase III
- Phase IV
By End-User:
- Hospitals
- CROs
- Academic institutes
- Pharma & Biotech Organizations
- Medical Device Manufacturers
By Country:
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of APAC
Regional Analysis:
The eClinical solutions market in the Asia-Pacific market is believed to showcase a fast pace during the forecast period. Increasing demand for e-clinical solutions in the region's market is to drive growth during the period.
Japan is dominating the e-clinical solutions in the market of the region, followed by China. The market in Japan is ascribed by factors like a surge in research and expenditure activities by pharmaceutical and biotechnology companies for the enhancements in drugs that are propelling the region.
China is next to Japan to lead the Asia Pacific eClinical solutions market and is expected to perform well during the forecast period. The Chinese market is strongly supported by government funds and investments' advancements to assist the clinical research to be carried on.
India is believed to be the quickest growing country in the region. Factors like a massive increase in the elder people population, an expected increase in chronic diseases like cancer, CVD conditions, and infectious diseases are surging the APAC market growth.
Notable companies operating in the Asia Pacific eClinical Solutions Market profiled in this report are Oracle Corporation, Medidata Solutions, Inc., Parexel International Corporation, Bioclinica, Inc., Datatrak International, Inc., CRF Health, ERT Clinical, Merge Healthcare Incorporated, Omnicomm Systems, Inc., Maxisit Inc., Bio-Optronics, Inc., and Eclinical Solutions, LLC.
- Introduction
- Market Definition
- Study Deliverables
- Base Currency, Base Year and Forecast Periods
- General Study Assumptions
- Research Methodology
- Introduction
- Research Phases
-
- Secondary Research
- Primary Research
- Econometric Modelling
- Expert Validation
- Analysis Design
- Study Timeline
- Overview
- Executive Summary
- Key Inferences
- New Developments
- Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
- Market Drivers
- Market Restraints
- Key Challenges
- Current Opportunities in the Market
- Market Segmentation
- By Products and Services
- Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
- Clinical Trial Management Systems (CTMS)
- Clinical Analytics Platform
- Randomization and Trial Supply Management (RTMS)
- Clinical Data Integration Platform
- Electronic Clinical Outcome Assessment (eCOA)
- Safety Solutions
- Electronic Trial Master Files (eTMF)
- Regulatory Information Management Solutions (RIMS)
- Others
- Y-o-Y Growth Analysis, By Products and Services
- Market Attractiveness Analysis, By Products and Services
- Market Share Analysis, By Products and Services
- By Delivery Mode
- Web-hosted (On-demand)
- Licensed Enterprise (On-premise)
- Cloud-based
- Y-o-Y Growth Analysis, By Delivery Mode
- Market Attractiveness Analysis, By Delivery Mode
- Market Share Analysis, By Delivery Mode
- By Development Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Y-o-Y Growth Analysis, By Development Phase
- Market Attractiveness Analysis, By Development Phase
- Market Share Analysis, By Development Phase
- By End Users
- Hospitals
- CROs
- Academic institutes
- Pharma & Biotech Organizations
- Medical Device Manufacturers
- Y-o-Y Growth Analysis, By End Users
- Market Attractiveness Analysis, By End Users
- Market Share Analysis, By End Users
- Geographical Analysis
- Introduction
- Regional Trends
- Impact Analysis
- Y-o-Y Growth Analysis
- By Geographical Area
- By Product
- By Technology
- By Application
- By End-User
- Market Attractiveness Analysis
- By Geographical Area
- By Product
- By Technology
- By Application
- By End-User
- Market Share Analysis
- By Geographical Area
- By Product
- By Technology
- By Application
- By End-User
- Asia Pacific
- Introduction
- India
- China
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Strategic Analysis
- PESTLE analysis
- Political
- Economic
- Social
- Technological
- Legal
- Environmental
- Porter’s Five analysis
- Bargaining Power of Suppliers
- Bargaining Power of Consumers
- Threat of New Entrants
- Threat of Substitute Products and Services
- Competitive Rivalry within the Industry
- Market Leaders' Analysis
- Oracle Corporation
- Overview
- Product Analysis
- Strategic Evaluation and Operations
- Financial analysis
- Legal issues
- Recent Developments
- SWOT analysis
- Analyst View
- Medidata Solutions, Inc.
- Parexel International Corporation
- Bioclinica, Inc.
- Datatrak International, Inc.
- CRF Health
- ERT Clinical
- Merge Healthcare Incorporated
- Omnicomm Systems, Inc.
- Maxisit Inc.
- Bio-Optronics, Inc.
- Eclinical Solutions, LLC.
- Competitive Landscape
- Market share analysis
- Merger and Acquisition Analysis
- Agreements, Collaborations and Joint Ventures
- New Product Launches
- Market Outlook and Investment Opportunities
- Appendix
- List of Tables
- List of Figures
- Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
- Segment-level analysis in terms of product, delivery mode, development phase, end-user, and region along with market size forecasts and estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
- Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
- A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
- Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
